Motusium Partners with H Robotics to Bring FDA-Registered Rebless™ to the U.S. Market
Motusium, the Austin-based healthcare startup known for its advanced rehabilitation solutions, has announced a groundbreaking partnership with H Robotics, becoming the exclusive U.S. distributor of H Robotics' FDA-registered medical device, rebless™. This collaboration marks a significant advancement in the field of neurorehabilitation, as Motusium brings the state-of-the-art rebless™ technology to American patients.
Founded in 2018, H Robotics has rapidly become a leading name in the development, manufacturing, and distribution of innovative rehabilitation solutions, particularly for individuals suffering from neurological and musculoskeletal conditions. Their flagship product, rebless™, is a testament to their commitment to improving quality of life through data-driven technology. With its FDA registration, rebless™ stands as a symbol of trusted and effective rehabilitation technology.
Motusium, with its focus on integrating robotics and AI into healthcare, aligns perfectly with H Robotics' mission of creating healthier lives through innovation. This partnership not only enhances Motusium's product offering but also solidifies its position as a frontrunner in the U.S. rehabilitation technology market.
Motusium is an innovative leader in the healthcare industry, offering advanced rehabilitation solutions that leverage robotics and AI technology. Based in Austin, the company is dedicated to enhancing patient care with cutting-edge technologies for both clinical and home settings.
About H Robotics
H Robotics, established in 2018, specializes in robotic rehabilitation solutions, blending software and robotic technology to create products that add value to customers and contribute to healthier lives globally. With a string of achievements including CES Innovation Awards in 2021 and 2022, H Robotics is on a mission to lead the 21st-century market in robotic devices for neurological and musculoskeletal patients.
Andrew W. Chang